NVO in 2026

AI Summary

Author asks whether FDA approval of oral Ozempic makes NVO a long-term value opportunity despite recent declines.

NVO — LONG The author cites FDA approval for Novo Nordisk's oral Ozempic in the US as a catalyst. They considered NVO a good long-term value stock for roughly two years but note recent price declines. The author is considering investing a small amount to test the opportunity.

Novo Nordisk (NVO) got FDA approval recently to officially sell their pill version of Ozempic in the US. I thought this would be a good value stock to keep for long term (2 year-ish), but it seems to be going to opposite direction.

Score 1

Comments 1

▶ Full Post Text

Ideas

u/LankyBuffalo7879 Reddit r/wallstreetbets

Oral Ozempic FDA approval supports NVO long-term value

The author cites FDA approval for Novo Nordisk's oral Ozempic in the US as a catalyst. They considered NVO a good long-term value stock for roughly two years but note recent price declines. The author is considering investing a small amount to test the opportunity.

This Reddit post, published January 01, 2026, features u/LankyBuffalo7879 discussing NVO. 1 trade idea extracted by AI with direction and confidence scoring.

Speakers: u/LankyBuffalo7879 · Tickers: NVO

▶ Full Post Text

Ideas

More from Reddit — r/wallstreetbets